Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Privia Health GroupPRVA -1.63%88 Debt-to-EBITDA is 0.21 as of Mar. 2026, which is 9% below its 10-year median of 0.23. GuruFocus rates PRVA with a GF Score™ of 88/100 and a GF Value™ of $27.54 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Privia Health Group ranks better than 88.89% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Privia Health Group's Debt-to-EBITDA or its related term are showing as below:
PRVA'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.79 Med: 0.23 Max: 2.46
Current: 0.19
During the past 8 years, the highest Debt-to-EBITDA Ratio of Privia Health Group was 2.46. The lowest was -0.79. And the median was 0.23.
PRVA's Debt-to-EBITDA is ranked better than 88.89% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 2.22
vs PRVA: 0.19
Privia Health Group (NAS:PRVA) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Privia Health Group Debt-to-EBITDA Related Terms
Privia Health Group Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Privia Health Group's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PRVA vs HTFL, WAY, DOCS: Debt-to-EBITDA Comparison
For the Health Information Services subindustry, Privia Health Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Privia Health Group Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Privia Health Group's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Privia Health Group's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Privia Health Group (PRVA) has a Debt-to-EBITDA of 0.21 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Privia Health Group. This is near median its historical median of 0.23. According to the industry distribution chart, Privia Health Group ranks #53 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 11.1%.
Is Privia Health Group's Debt-to-EBITDA too high?
Privia Health Group's current Debt-to-EBITDA of 0.21 is near median its 10-year median of 0.23. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.22. Privia Health Group's value of 0.21 is 90.5% below this industry median. Based on the distribution chart, Privia Health Group ranks #53 out of 477 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Privia Health Group has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Privia Health Group's Debt-to-EBITDA compare to HTFL and WAY?
According to the Healthcare Providers & Services industry distribution chart, Privia Health Group ranks #53 out of 477 companies for Debt-to-EBITDA. This places Privia Health Group in the top 11% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.22. Privia Health Group's value of 0.21 is 90.5% below this benchmark. While the company's 10-year median is 0.23 vs. the industry median of 2.22, Privia Health Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.22, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Privia Health Group's current Debt-to-EBITDA of 0.21 is 90.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Privia Health Group. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Privia Health Group's current Debt-to-EBITDA is 0.21, which is near median its own 10-year median of 0.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Privia Health Group stock overvalued right now?
Based on GuruFocus' analysis, Privia Health Group (PRVA) is currently considered Modestly Undervalued. The stock's GF Value™ is $27.54, compared to a current price of $24.97 — trading 9.3% below its estimated fair value. The current Debt-to-EBITDA is 0.21, which is near median its 10-year median of 0.23 and 90.5% below the Healthcare Providers & Services industry median of 2.22. Privia Health Group's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Privia Health Group (PRVA), the current Debt-to-EBITDA is 0.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Privia Health Group (PRVA) Overvalued in 2026?
Based on GuruFocus' analysis, Privia Health Group stock appears to be undervalued.
The current stock price of $24.97 is trading 9.3% below its estimated GF Value™ of $27.54.
GuruFocus considers Privia Health Group to be Modestly Undervalued.
Key valuation signals for PRVA:
Debt-to-EBITDA: 0.21 (near median its 10-year median of 0.23)
GF Value™: $27.54 vs. price of $24.97 (9.3% below fair value)
Industry Position: 90.5% below the Healthcare Providers & Services median (#53 of 477)
No single metric tells the full story. See the PRVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.
88GF Score
Get the complete analysis for PRVA
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRVA has been successfully added to your 
